Protein Sciences will start the search for two new H7N9 vaccine candidates by request of the HHS’ Biomedical Advanced Research and Development Authority.

Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

Add PaxVax to the list of companies vying to put the first Chikungunya vaccine on the market.

Bristol-Myers and Bavarian Nordic kicked off testing of the Big Pharma's checkpoint inhibitor Opdivo alongside the biotech's cancer vaccine CV301 in…

The Bill & Melinda Gates Foundation shelled out $12 million on a low-cost inactivated polio vaccine manufacturing platform as supplies to international…

With €5 million in government funding, Themis and European collaborators have teamed up to create the newest Zika vaccine partnership.

The CDC has signed a $911 million contract to stockpile Emergent BioSolutions' BioThrax.

Tech billionaire Sean Parker’s startup Parker Institute for Cancer Immunotherapy has paired with the legacy Cancer Research Institute to advance development of…

Deals